Macrocyclic Peptides Uncover a Novel Binding Mode for Reversible Inhibitors of LSD1
Main Authors: | Jie Yang, Vladimir O. Talibov, Stefan Peintner, Claire Rhee, Vasanthanathan Poongavanam, Matthis Geitmann, Matteo Rossi Sebastiano, Bernd Simon, Janosch Hennig, Doreen Dobritzsch, U. Helena Danielson, Jan Kihlberg |
---|---|
Format: | Article |
Language: | English |
Published: |
American Chemical Society
2020-02-01
|
Series: | ACS Omega |
Online Access: | https://doi.org/10.1021/acsomega.9b03493 |
Similar Items
-
Conformational Sampling of Macrocyclic Drugs in Different Environments: Can We Find the Relevant Conformations?
by: Vasanthanathan Poongavanam, et al.
Published: (2018-09-01) -
Conformation of the Macrocyclic Drug Lorlatinib in Polar and Nonpolar Environments: A MD Simulation and NMR Study
by: Cheng Peng, et al.
Published: (2019-12-01) -
Solubility prediction in the bRo5 chemical space: where are we right now?
by: Giuseppe Ermondi, et al.
Published: (2020-07-01) -
Virtual screening models for prediction of HIV-1 RT associated RNase H inhibition.
by: Vasanthanathan Poongavanam, et al.
Published: (2013-01-01) -
Computational Modeling Explains the Multi Sterol Ligand Specificity of the N‑Terminal Domain of Niemann–Pick C1-Like 1 Protein
by: Vasanthanathan Poongavanam, et al.
Published: (2019-12-01)